These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma. Christensen TT; Frystyk J; Poulsen PL Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043 [TBL] [Abstract][Full Text] [Related]
6. Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma. Eisenhofer G; Peitzsch M; Bechmann N; Huebner A Front Endocrinol (Lausanne); 2022; 13():901760. PubMed ID: 35957826 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors. Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804 [TBL] [Abstract][Full Text] [Related]
8. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma. Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605 [TBL] [Abstract][Full Text] [Related]
15. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients. Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307 [TBL] [Abstract][Full Text] [Related]
16. Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias. Martínez-Morillo E; Valdés Gallego N; Eguia Ángeles E; Fernández Fernández JC; Prieto García B; Álvarez FV Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):312-319. PubMed ID: 30391255 [TBL] [Abstract][Full Text] [Related]
17. Urinary clonidine suppression testing for the diagnosis of pheochromocytoma. Goupil R; Fountoulakis S; Gordon RD; Stowasser M J Hypertens; 2015 Nov; 33(11):2286-93. PubMed ID: 26335433 [TBL] [Abstract][Full Text] [Related]
18. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine. Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873 [TBL] [Abstract][Full Text] [Related]
19. Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions. Därr R; Pamporaki C; Peitzsch M; Miehle K; Prejbisz A; Peczkowska M; Weismann D; Beuschlein F; Sinnott R; Bornstein SR; Neumann HP; Januszewicz A; Lenders J; Eisenhofer G Clin Endocrinol (Oxf); 2014 Apr; 80(4):478-86. PubMed ID: 24102244 [TBL] [Abstract][Full Text] [Related]
20. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use. Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]